Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

847706

registered interest
date	23/02/2018
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	High Speed Two
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, pursuant to the Answer of 18 January 2018 to Question 122605 will he publish the clauses of the contract between HS2 Ltd and CEK JV for HS2 that guarantee the full delivery of the HS2 contract now that Carillion is unable to fulfil any part of that contract.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	129383
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>As a Joint Venture CEK were subject to the following contractual clause:</p><p> </p><p><strong>Z12 Joint and several liability</strong></p><p>Z12.1 If the <em>Contractor</em> is a Joint Venture</p><p>(1) each of the parties comprising the Joint Venture are jointly and severally liable to the <em>Employer</em> for the performance of this contract and all liabilities, acts and omissions of the <em>Contractor</em> under or in connection with this contract are the liabilities, acts or omissions of each party comprising the Joint Venture under or in connection with this contract,</p><p>(2) without limiting or prejudicing any other provisions of this contract, if any of the parties comprising the Joint Venture ceases to be a member of the Joint Venture or suffers one of the events described in clause 91.1, the other parties or party carry out and complete the <em>works</em> in accordance with this contract,</p><p>(3) the <em>Contractor</em> gives notice to the <em>Employer</em> and the <em>Project Manager</em> as to which of the parties comprising the Joint Venture has the authority to bind the <em>Contractor</em> for all the purposes of this contract and</p><p>(4) the <em>Contractor</em> keeps the <em>Employer</em> and the <em>Project Manager</em> informed promptly of any changes in the Joint Venture whether in relation to any incorporated entity or its constituent entities or the entities forming an unincorporated joint venture, including changes in legal status, the occurrence of any of the events described in clause 91.1, amalgamation, demerger, merger, deterioration in financial condition, de-ratings, major legal claims and suits, and any other matter or circumstance that could reasonably be deemed to be of concern to the <em>Employer</em> or the <em>Project Manager</em>.</p><p> </p><p>[Regarding (4) above, Carillion Construction Limited was subject to an ‘event described in clause 91.1’ when it was put into liquidation on 15 January 2018]</p><p> </p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 28/02/2018 16:20:46 answering member 4460 label Biography information for Ms Nusrat Ghani
tabling member	18 label Biography information for Dame Cheryl Gillan

847707

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 January 2018 to Question 123454, what assessment he has made of the implications for his Department's policies of the decline in life expectancy in some local authority areas and the disparity in life expectancy across local authorities.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	129512
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>We recognise that the causes of health inequalities are multi-faceted and highly complex. We take a comprehensive and strategic approach to reducing health inequalities that addresses the root social causes, promotes healthier lifestyles for all and improves the consistency of NHS services.</p><p> </p><p>We have taken tough action to protect the public’s health - introducing a sugar tax as part of our childhood obesity plan, standardised packaging cigarettes and a world-leading diabetes prevention programme. It will take time for these measures to have an effect, so no assessment of their impact has been made. Our commitment is demonstrated by the £16 billion we will invest over the current spending period until 2020 to support local public health services. Local authorities must consider health inequalities when investing this ring-fenced money.</p><p> </p><p>We have introduced transparent measurement through high level measures to reduce health inequalities in life expectancy and healthy life expectancy in the Public Health Outcomes Framework and NHS Outcomes Framework. In March 2015, we published an additional list of selected NHS Outcomes Framework indicators for which health inequalities data has been made available. Last year Public Health England (PHE) published a report entitled ‘Public Health Outcome Framework: Health Equity Report’, which provides detailed statistics on the distribution and drivers of health inequality across England, with a specific focus on ethnicity. The report is available at:</p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/629563/PHOF_Health_Equity_Report.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/629563/PHOF_Health_Equity_Report.pdf</a></p><p> </p><p>PHE has published a number of statistics, evidence reports and tools to enable local government and the wider public health system to take effective action on health equity.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2018 17:21:29 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

847708

registered interest
date	23/02/2018
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Supply Teachers: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, what assessment he has made of the (a) adequacy and (b) extent of the provision of safeguarding training provided by supply teacher agencies in the UK.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	129384
answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>Schools are responsible for ensuring that all staff, including supply staff, are aware of their safeguarding responsibilities. ‘Keeping Children Safe in Education’ statutory safeguarding guidance makes clear that all staff should read ‘Part One - Safeguarding information for all staff at induction’. It also requests that governing bodies/proprietors ensure that mechanisms are in place to support staff to understand and discharge their role and responsibilities as set out in Part One. The guidance states that all staff should receive safeguarding and child protection training at induction.</p><p> </p><p>Before placing a member of staff a supply agency must request sufficient information, including the experience, references, training, and qualifications the school needs for the post or that are required by law.</p><p> </p><p>To help schools achieve best value when using supply agencies the Department is working with the Crown Commercial Service to develop a commercial framework for agency supply teachers. Together with other requirements the framework will ensure that agencies adhere to standard levels of practice. The framework is expected to be available for schools to use from September 2018.</p> answering member constituency Bognor Regis and Littlehampton answering member printed Nick Gibb question first answered 05/03/2018 17:04:09 answering member 111 label Biography information for Nick Gibb
tabling member	534 label Biography information for Chris Ruane

847709

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mast Cell Activation Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of allowing the use of off-label medications in the treatment of Mast Cell Activation Syndrome.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	129385
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>We have made no such assessment. Prescribers are able to use medicinal products outside their licensed indications where they are satisfied that they best meet the individual clinical needs of their patient. This is part and parcel of normal clinical practice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2018 17:18:23 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

847710

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mast Cell Activation Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the accuracy of the coding of diagnoses of Mast Cell Activation Syndrome on NHS systems.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	129386
answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>NHS England does not have any current plans to assess the coding of National Health Service care for patients with Mast Cell Activation Syndrome.</p><p> </p><p>In response to the commitments outlined in the UK Strategy for Rare Diseases, NHS England published the Rare Diseases Implementation Plan in which it proposed to monitor the development of International Classification of Diseases (ICD)-11 and support the accurate characterisation of patients through Human Phenotype Ontology terms as being developed through the 100,000 Genomes Project.</p><p> </p><p>More information about the NHS England Rare Diseases Implementation Plan can be found here:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/implementation-plan-for-the-uk-strategy-for-rare-diseases/" target="_blank">https://www.england.nhs.uk/publication/implementation-plan-for-the-uk-strategy-for-rare-diseases/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2018 15:41:57 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

847711

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mast Cell Activation Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will establish a multi-disciplinary centre of excellence with leadership from a senior clinician to focus on Mast Cell Activation Syndrome.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	129387
answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>Care for patients with Mast Cell Activation Syndrome (MCAS) in an outpatient setting will typically be within local allergy clinics, available in most hospitals. These services are commissioned locally by clinical commissioning groups. There are no current plans to designate or commission the care of patients with MCAS as a prescribed national specialised clinic or service.</p><p> </p><p>A list of local allergy clinics can be obtained from the British Society for Allergy and Clinical Immunology at:</p><p> </p><p><a href="http://www.bsaci.org/professionals/allergy-specialists" target="_blank">http://www.bsaci.org/professionals/allergy-specialists</a></p><p> </p><p>The Royal College of Physician’s Improving Quality in Allergy Services scheme at:</p><p> </p><p><a href="http://www.rcplondon.ac.uk/projects/outputs/improving-quality-allergy-services" target="_blank">www.rcplondon.ac.uk/projects/outputs/improving-quality-allergy-services</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2018 15:44:46 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

847712

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mast Cell Activation Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will include Mast Cell Activation Syndrome (MCAS) in the 100K genome project and establish links to the MCAS Research Centre at the University of Bonn Institute of Genetics.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	129388
answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>Mast Cell Activation Syndrome (MCAS) does not currently have a specific disease category within the 100,000 Genomes Project but patients with MCAS in the context of other medical disorders or congenital malformations suggestive of a genetic cause are eligible. In addition, a proposal for inclusion of familial MCAS in the project is currently under peer review and will be considered by the Genomics England Science Advisory Committee at their next meeting.</p><p> </p><p>Genomics England will seek to establish links between the relevant Genomics England Clinical Interpretation Partnership (GeCIP) domains and the MCAS Research Centre at the University Of Bonn Institute Of Genetics.</p><p> </p><p>More about GeCIP can be found here:</p><p> </p><p><a href="https://www.genomicsengland.co.uk/about-gecip/" target="_blank">https://www.genomicsengland.co.uk/about-gecip/</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/03/2018 16:19:20 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	18 label Biography information for Dame Cheryl Gillan

847713

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: North West
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 February 2018 to Question 127707, what information his Department holds on the number of nurse vacancies and in what format such information is held.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	129389
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>NHS Digital publishes the number of vacancies that are advertised on NHS Jobs, the dedicated online recruitment service for the National Health Service. However, as the basis of the figures is the number of vacancies advertised for the first time in each given month, it is not possible to determine from these figures the number of vacancies live at any given point in time. The figures only cover those vacancies advertised via NHS Jobs, and it is not always possible to determine how many posts are associated with any given advertisement. The published figures are at the Health Education England region and do not go to the level of individual trusts.</p><p> </p><p>This data is relatively new and there is limited data to establish trends. It is also important to note the distinction between job adverts and actual vacancies as many trusts are in a constant process of recruitment with single job adverts often covering multiple job vacancies.</p><p> </p><p>The latest NHS Digital figures show that over 34,000 nursing and midwifery vacancies were advertised in the three months to September 2017 across England.</p><p> </p><p>The NHS Digital vacancy figures are available at the following link:</p><p> </p><p><a href="http://www.digital.nhs.uk/catalogue/PUB30196" target="_blank">www.digital.nhs.uk/catalogue/PUB30196</a></p><p>NHS Jobs data from NHS Digital is not the only source of vacancy data.</p><p> </p><p>NHS Improvement have produced their own estimates and analysis for vacancy numbers.</p><p> </p><p>NHS Improvement figures represent management information only and are not an official statistic. Their data for nursing and midwifery shows that there are 35,835 full time equivalent nursing and midwifery vacancies, of these approximately 31,351 (87%) are filled by temporary staff (32% agency and 55% bank).</p><p> </p><p>The latest NHS Improvement vacancy figures are available at the following link:</p><p> </p><p><a href="http://www.improvement.nhs.uk/resources/quarterly-performance-nhs-provider-sector-quarter-3-201718/" target="_blank">www.improvement.nhs.uk/resources/quarterly-performance-nhs-provider-sector-quarter-3-201718/</a></p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 28/02/2018 13:02:31 answering member 4095 label Biography information for Steve Barclay
tabling member	432 label Biography information for Helen Jones

847714

registered interest
date	23/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Parking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 February 2018 to Question 127703, what information his Department holds on the level of hospital car parking charges and on what basis he decides whether the NHS has carried out its duty to ensure that charges are applied fairly.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	129390
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>National Health Service car parking data including level of hospital car parking charges at NHS trusts is collected annually through Estates Return Information Collection.</p><p> </p><p>The latest available data for 2016-17 confirms the national average fee charges per hour for patients and visitors are £1.32 and £0.19 for staff.</p><p> </p><p>NHS organisations are responsible locally for their own policy on car parking, taking into account operational circumstances and community interests.</p><p> </p><p>The NHS patient, visitor and staff car parking principles (first published in August 2014 and then updated in October 2015), set out a nationally consistent approach to determining car parking policies, making clear the rules which NHS trusts should follow when making decisions about car parking. However, the provision of parking spaces and the level of any charges that are made to use them are matters for individual NHS trusts.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 28/02/2018 13:25:19 answering member 4095 label Biography information for Steve Barclay
tabling member	432 label Biography information for Helen Jones

847715

registered interest
date	23/02/2018
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Personal Injury: Compensation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, what assessment he has made of the effect of changes to the personal injury discount rate on average motor insurance premiums.
tabling member constituency	Preseli Pembrokeshire
tabling member printed	Stephen Crabb
uin	129391
answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>The Government has not made an estimate of the overall impact on the insurance industry of the change to the discount rate in March 2017. However, in September 2017, PwC stated insurers had passed on roughly half of the expected costs resulting from the change in the rate with premiums for policies rising by about £75 on average and about £250 for young drivers.</p> answering member constituency Penrith and The Border answering member printed Rory Stewart question first answered 05/03/2018 17:22:46 answering member 4137 label Biography information for Rory Stewart
tabling member	1554 label Biography information for Stephen Crabb